Third Affiliated Hospital, Sun Yat-sen University

This study tests a new first-line treatment for people with advanced liver cancer that cannot be removed by surgery. The treatment combines a procedure that delivers chemotherapy directly to the tumor (TACE) with two drugs that boost the immune system and block blood vessel growt…

This study tests a new drug combination for people with advanced liver cancer that cannot be surgically removed. Participants will receive two immunotherapy drugs (adebrelimab and low-dose bevacizumab) along with a two-step procedure that delivers chemotherapy directly to the liv…

This study tests a new treatment for people with advanced liver cancer that cannot be surgically removed. The treatment combines low doses of two drugs (bevacizumab and atezolizumab) with a procedure that delivers chemotherapy directly to the liver. The goal is to see if this app…

This early study is testing whether a patient's own concentrated growth factors can help restore movement, sensation, and bodily functions after spinal cord injury. Ten participants will have these growth factors implanted at their injury site along with standard rehabilitation t…

This study tests whether a virtual health community can help adults with prediabetes improve blood sugar control and prevent type 2 diabetes. Participants will receive lifestyle education, guidance, and group support through a digital platform for 6 months. The goal is to see if …